CONCERNING NEW STANDARDS OF TREATMENT OF THE PERIPHERAL ARTERIES DISEASES ON BACKGROUND OF MODERN RECOMMENDATIONS AND DATA OF CLINICAL INVESTIGATIONS, TAKING INTO ACCOUNT A SIGNIFICANCE OF PROPHYLAXIS OF UNFAVORABLE EVENTS WITH THE EXTREMITY AND CARDIO-VA

  • CONSENSUS OF EXPERTS

Abstract

CONCERNING NEW STANDARDS OF TREATMENT OF THE PERIPHERAL ARTERIES DISEASES ON BACKGROUND OF MODERN RECOMMENDATIONS AND DATA OF CLINICAL INVESTIGATIONS, TAKING INTO ACCOUNT A SIGNIFICANCE OF PROPHYLAXIS OF UNFAVORABLE EVENTS WITH THE EXTREMITY AND CARDIO-VA

References

Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40. doi: 10.1016/S0140-6736(13)61249-0. Epub 2013 Aug 1. PMID: 23915883.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67. doi: 10.1016/j.jvs.2006.12.037. PMID: 17223489.

European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851-906. doi: 10.1093/eurheartj/ehr211. Epub 2011 Aug 26. PMID: 21873417.

Alonso-Coello P, Bellmunt S, McGorrian C, Anand SS, Guzman R, Criqui MH, et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e669S-e690S. doi: 10.1378/chest.11-2307. PMID: 22315275; PMCID: PMC3278062.

Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):1465-1508. doi: 10.1016/j.jacc.2016.11.008. Epub 2016 Nov 13. Erratum in: J Am Coll Cardiol. 2017 Mar 21;69(11):1520. PMID: 27851991.

Bonaca MP, Gutierrez JA, Creager MA, Scirica BM, Olin J, Murphy SA, et al. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Circulation. 2016;133(10):997-1005. doi: 10.1161/CIRCULATIONAHA.115.019355. Epub 2016 Jan 29. PMID: 26826179.

Sigvant B, Hasvold P, Kragsterman B, Falkenberg M, Johansson S, Thuresson M, et al. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study. J Vasc Surg. 2017;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19. PMID: 28433332.

Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, et al. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation. 2017;135(3):241-250. doi: 10.1161/CIRCULATIONAHA.116.025880. Epub 2016 Nov 13. PMID: 27840336.

Belch JJ, Dormandy J; CASPAR Writing Committee, Biasi GM, Cairols M, Diehm C, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010;52(4):825-33, 833.e1-2. doi: 10.1016/j.jvs.2010.04.027. Epub 2010 Aug 1. Erratum in: J Vasc Surg. 2011;53(2):564. Biasi, B M [corrected to Biasi, G M]. PMID: 20678878.

Fox KAA, Eikelboom JW, Anand SS, Bhatt DL, Bosch J, Connolly SJ, et al. Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? Eur Heart J. 2019;40(18):1466-1471. doi: 10.1093/eurheartj/ehy347. PMID: 29945212.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med. 2017;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. PMID: 28844192.

Anand SS, Bosch J, Eikelboom JW, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219-229. doi:10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. PMID: 29132880.

Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, et al. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). Am Heart J. 2018;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3. PMID: 29754671.

Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28. PMID: 32222135.

Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Lüders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36(15):932-8. doi: 10.1093/eurheartj/ehv006. Epub 2015 Feb 2. PMID: 25650396.

Ministry of Health of Ukraine. The Ministry of Health of Ukraine is launching an online platform with protocols based on evidence-based medicine. 2018 May 15. [Internet]. Available from: https://moz.gov.ua/article/news/moz-ukraini-zapuskae-onlajn-platformu-z-protokolami-na-zasadah-dokazovoi-medicini- [In Ukrainian].

Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, et al. ESVM Guideline on peripheral arterial disease. Vasa. 2019;48(Suppl 102):1-79. doi: 10.1024/0301-1526/a000834. PMID: 31789115.

Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28. Erratum in: J Vasc Surg. 2019 Aug;70(2):662. PMID: 31159978.

Published
2020-07-24
How to Cite
OF EXPERTS, C. (2020). CONCERNING NEW STANDARDS OF TREATMENT OF THE PERIPHERAL ARTERIES DISEASES ON BACKGROUND OF MODERN RECOMMENDATIONS AND DATA OF CLINICAL INVESTIGATIONS, TAKING INTO ACCOUNT A SIGNIFICANCE OF PROPHYLAXIS OF UNFAVORABLE EVENTS WITH THE EXTREMITY AND CARDIO-VA. Klinicheskaia Khirurgiia, 87(5-6), 102-104. https://doi.org/10.26779/2522-1396.2020.5-6.102